Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPHC.L Regulatory News (PHC)

  • There is currently no data for PHC

Director/PDMR Shareholding

31 Jan 2007 07:01

Plant Health Care PLC31 January 2007 31 January 2007 Plant Health Care PLC ("Plant Health Care" or "the Company") Directors' Dealings Directors' Exercise of Options The Company was notified on 30 January 2007 that, on the same day, Dr DonaldMarx, a director of the Company, exercised options over 715,761 ordinary sharesof 1p each in the Company ("Ordinary Shares") at an exercise price of 37 penceper Ordinary Share and options over 34,237 Ordinary Shares at an exercise priceof 71 pence per Ordinary Share. Accordingly, on 30 January 2007 Dr Marxexercised a total of 749,998 options over Ordinary Shares. The Company was notified on 30 January 2007 that, on the same day, Mr JohnBrady, a Director of the Company, exercised options over 300,000 Ordinary Sharesat a price of 37 pence per Ordinary Share. Directors' Dealings The Company was notified on 30 January 2007 that, on the same day Dr Marx and MrBrady sold 900,000 Ordinary Shares and 300,000 Ordinary Shares respectively allat a price of 225 pence per Ordinary Share. All of these 1.2 million OrdinaryShares sold by Dr Marx and Mr Brady were as a result of the exercise of options(described above), with the exception of 150,002 Ordinary Shares held by DrMarx. Directors' Interests and Admission of Ordinary Shares Following the exercise of options and share sales described above, thebeneficial interests of the directors in the Company's Ordinary Share capitalare set out below: Name Ordinary Percentage of Share Options Shareholding issued Ordinary Share capital Dr Albert Fischer 143,371 0.35% 225,000John Brady Nil Nil 1,200,000Walter Bratkowski Nil Nil 200,000Dr Robert Chanson 135,166 0.33% 210,000Thomas Isler 400,846 0.97% 202,500Dr Donald Marx 428,813 1.04% 3,470Samuel Wauchope 52,232 0.13% Nil Application has been made for 1,049,998 Ordinary Shares being issued pursuant tothe exercise of options described above, to be admitted to trading on the LondonStock Exchange's AIM market for listed securities ("Admission"). Admission isexpected to occur on 5 February 2007. The New Shares will rank pari passu withthe Company's existing Ordinary Shares. Following admission of the New Shares, the total issued share capital of the Company will be 41,428,422 Ordinary Shares, all of which have voting rights. The above figure (41,428,422) may be used by shareholders as the denominator forthe calculations by which they will determine if they are required to notifytheir interest in, or a change to their interest in, Plant Health Care plc underthe FSA's Disclosure and Transparency Rules. For further information: Tavistock ComunicationsJeremy Carey/Matt RidsdaleTel: +44 20 7920 3150 Plant Health Care PLCAndrew Wood, Company Secretary Tel: +44 (0) 20 8866 5702 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
12th Nov 20193:56 pmRNSHolding(s) in Company
6th Nov 201912:57 pmRNSInvestment in Company by Ospraie Ag Science LLC
30th Oct 20197:00 amRNSAppointment of new Board Directors
3rd Oct 20192:50 pmRNSDirector/PDMR Shareholding
30th Sep 20197:00 amRNSInterim Report ended 30 June 2019
9th Sep 20197:00 amRNSPilot production of PREtec peptides
19th Aug 20197:00 amRNSBlock listing Interim Review
15th Aug 20197:00 amRNSProgress with PREtec field trials in Brazil
5th Aug 20195:18 pmRNSHolding(s) in Company
25th Jun 20197:00 amRNSNew Distribution Agreement with Wilbur-Ellis
12th Jun 201911:05 amRNSResult of AGM
30th Apr 20194:19 pmRNSAnnual Report & Accounts and AGM Notice Published
10th Apr 20197:00 amRNSResults for the year ended 31 December 2018
27th Mar 20193:41 pmRNSHolding(s) in Company
28th Feb 20197:00 amRNSNew Technology Update
19th Feb 20197:00 amRNSBlock listing Interim Review
29th Jan 20197:00 amRNSTrading Statement
24th Jan 20195:58 pmRNSHolding(s) in Company
21st Dec 20187:00 amRNSTrading Statement
28th Nov 20187:00 amRNSNew Technology Update
21st Nov 20187:00 amRNSPlant Health Care ProAct® Wins Top Industry Award
19th Nov 20187:00 amRNSPlant Health Care to present at Mello London
14th Nov 20187:00 amRNSPositive Developments with Harpin
8th Nov 20187:00 amRNSChange of Adviser
5th Nov 20187:00 amRNSHolding(s) in Company
18th Sep 20187:00 amRNSInterim Report ended 30 June 2018
12th Sep 20187:00 amRNSUS Announces Harpin aß Product Launch in Corn
20th Aug 20187:00 amRNSBlock listing Interim Review
30th Jul 20187:00 amRNSUpdate on sugarcane in Brazil
16th Jul 20187:00 amRNSTrading Statement
6th Jun 20182:39 pmRNSHolding(s) in Company
6th Jun 201811:14 amRNSResult of AGM
30th May 20187:00 amRNSGrant of Options
4th May 20185:59 pmRNSHolding(s) in Company
30th Apr 20183:11 pmRNSPublication of Annual Report and Notice of AGM
10th Apr 20187:00 amRNSResults for the year ended 31 December 2017
8th Mar 20187:00 amRNSBlock listing Interim Review
7th Mar 20183:07 pmRNSHolding(s) in Company
7th Mar 20183:06 pmRNSHolding(s) in Company
7th Mar 20183:02 pmRNSHolding(s) in Company
2nd Mar 20185:48 pmRNSHolding(s) in Company
27th Feb 20184:12 pmRNSResult of Placing and Subscription
27th Feb 20187:00 amRNSProposed Placing and Subscription
24th Jan 20187:00 amRNSTrading Statement
12th Dec 20177:00 amRNSNew Technology Update
8th Dec 20174:35 pmRNSPrice Monitoring Extension
6th Dec 20174:40 pmRNSSecond Price Monitoring Extn
6th Dec 20174:35 pmRNSPrice Monitoring Extension
18th Sep 20177:00 amRNSHalf-year Report
21st Aug 20177:00 amRNSBlock listing Interim Review

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.